公司资料
Basilea Pharmaceutica 股价、新闻与催化剂
- 股票代码:
- BSLN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- Switzerland and trades in the U
股价为何变动
Current closing-price context is not available for BSLN.
公司概览
业务概览
Basilea Pharmaceutica is a specialty pharmaceutical company focused on infectious disease and oncology. Its business combines marketed products and development activity in niche therapeutic areas.
所在地与行业分类
Basilea is headquartered in Switzerland and trades in the U.S. market. It sits in specialty pharma and anti-infectives.
商业模式特征
The company depends on product revenue, pipeline progress, and strategic commercialization in focused markets. Investors watch earnings, product launches, and development milestones.
生物医药行业定位
Basilea occupies a specialty-pharma niche with catalyst sensitivity around infectious disease and oncology assets. It is more commercial than early-stage biotech but still tied to pipeline progress.
未来催化剂
- Basilea’s catalysts are antifungal and antibacterial product execution, plus any licensing or commercialization update that strengthens the portfolio. The company moves on steady recurring pharmaceutical demand.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。